Genetic disruption of soluble epoxide hydrolase is protective against streptozotocin-induced diabetic nephropathy
about
Cytochrome P450 eicosanoids in hypertension and renal diseaseSoluble epoxide hydrolase: A potential target for metabolic diseasesSoluble epoxide hydrolase: gene structure, expression and deletionA dual COX-2/sEH inhibitor improves the metabolic profile and reduces kidney injury in Zucker diabetic fatty ratTranscriptome-based analysis of kidney gene expression changes associated with diabetes in OVE26 mice, in the presence and absence of losartan treatment20-HETE and EETs in diabetic nephropathy: a novel mechanistic pathwayEpoxyeicosatrienoic acids attenuating hypotonic-induced apoptosis of IMCD cells via γ-ENaC inhibition.Impact of soluble epoxide hydrolase inhibition on early kidney damage in hyperglycemic overweight mice.Soluble epoxide hydrolase inhibitor enhances synaptic neurotransmission and plasticity in mouse prefrontal cortex.Cytochrome P450 (CYP) epoxygenases as potential targets in the management of impaired diabetic wound healing.Effect of Cytochrome P450 Metabolites of Arachidonic Acid in Nephrology.Role of haem oxygenase in the renoprotective effects of soluble epoxide hydrolase inhibition in diabetic spontaneously hypertensive rats.Inhibition of Soluble Epoxide Hydrolase 2 Ameliorates Diabetic Keratopathy and Impaired Wound Healing in Mouse Corneas.Blood glucose fluctuation accelerates renal injury involved to inhibit the AKT signaling pathway in diabetic rats.Association of EPHX2 R287Q Polymorphism with Diabetic Nephropathy in Chinese Type 2 Diabetic Patients.Understanding depression in type 2 diabetes: a biological approach in observational studies
P2860
Q28252210-1F52649E-BBB7-4A09-B22F-C9AC3D7612C5Q28270454-3AB88275-E776-494D-8FF5-46894AFB3EB7Q28291292-4FBB80BB-0129-4F2D-B1B5-0B4EC34388EAQ28390006-1AD27CA3-A689-4D32-B7C7-F0CF515231C9Q33610151-0FF24600-F6B7-4314-94A2-2A83105B3B92Q34924935-79E8CED7-211F-46B9-AF2D-B5E27F871546Q35142683-64C82EA6-CB92-4265-AEAC-3B9C370AAB51Q36074329-1401ECF6-58C3-4A6F-86FF-AFF3A868E9A8Q36202208-C3373844-D774-4D42-922B-1BBF3AB4853BQ38288640-CCA0A4AE-8078-4675-ADC2-2FEEADEFD745Q39431317-834D7906-2D4F-4422-9D2B-DCD1A050C511Q42711742-C2B20B64-E2C2-497B-A026-E482EFA5E51EQ52609150-1B59AC8A-9460-4834-BD02-0B8FB38DC44FQ53179601-54FC5E38-F30D-4FBE-A16D-9FC3FEBC94F7Q55248474-ECAF6B3F-4656-401D-9523-F530510CEC54Q58782352-3AB074DB-BD15-4230-8359-B11A81931540
P2860
Genetic disruption of soluble epoxide hydrolase is protective against streptozotocin-induced diabetic nephropathy
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 26 June 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Genetic disruption of soluble ...... n-induced diabetic nephropathy
@en
Genetic disruption of soluble ...... -induced diabetic nephropathy.
@nl
type
label
Genetic disruption of soluble ...... n-induced diabetic nephropathy
@en
Genetic disruption of soluble ...... -induced diabetic nephropathy.
@nl
prefLabel
Genetic disruption of soluble ...... n-induced diabetic nephropathy
@en
Genetic disruption of soluble ...... -induced diabetic nephropathy.
@nl
P2093
P2860
P1476
Genetic disruption of soluble ...... n-induced diabetic nephropathy
@en
P2093
Artiom Gruzdev
Dao Wen Wang
Guangzhi Chen
Peihua Wang
Yinna Wang
P2860
P304
P356
10.1152/AJPENDO.00591.2011
P577
2012-06-26T00:00:00Z